In a career spanning over 40 years in clinical stroke research I have been fortunate to observe interesting shifts in emphasis on how research is conducted and how it should be applied to the ultimate goal of producing and maintaining healthy and productive societies around the world. Forty years ago, most research being carried out in universities was laboratory based, and most career academics followed this path. Indeed, the minority of people who were involved in purely clinical research, were not regarded as serious academics. Gradually an interesting phenomenon occurred. Brain imaging with CT was introduced in the 1970s and clinical trial methodology emerged from the backwaters to dominate what became known as the translational research scene. I well remember research panels which were populated by basic scientists finding it hard to grasp the idea that imaging could be a serious scientific pursuit, even when animal based auto radiography was introduced.
The explosion of knowledge that imaging and clinical trial methodology produced soon overwhelmed the views of the few remaining recalcitrants. Suddenly, high profile clinical academics were leaders of departments and institutes globally and clinical research was well and truly on the map. To accommodate this the new term 'Translational research' was introduced with sophisticated sub sectioning from so called 'T1' or 'discovery science' right through to 'T4' or 'implementation research'.
Politicians, also grasped the translation nettle with enthusiasm because, with their love of short political cycle, they were able to report more immediate and tangible outcomes to their constituents.
But at what price did this come? There is no doubt that there has been a gradual erosion of support for fundamental discovery science around the world, particularly in the west. This trend has been accelerated by the viscitudes of economic cycles, pointedly the more recent global financial crisis of 2008. The breakaway from Europe by Britain is also likely to further exacerbate this problem in the United Kingdom. However, there are signs that this trend may be reversing. China, has been making significant investment in fundamental discovery science in recent decades, and this is now beginning to show in the number of highly ranked and cited publications coming from that country. No doubt, it will also flow to economic benefits as their discoveries travel down the T1-T4 pathway.
Another country which has seemingly bucked the trend is Canada where I was delighted to see that the Canadian Prime minister Trudeau announced that there would be almost $4 billion Canadian (US$3.1 billion) in funding for science over the next five years. With a significant portion predominately aimed at basic discovery science, leading the finance minister to state that it's ''the single largest investment in investigator-led fundamental research in Canadian history''.
An engine room of discovery to provide a pipeline of translational research through to clinical and commercial outcomes is an essential part of the fabric of modern society; human health and happiness is dependant upon it.
